sar
epidem
guangzhou
serum
specimen
collect
patient
day
onset
symptom
condit
patient
diagnos
accord
world
health
organ
criteria
confirm
seroconvers
fourfold
increas
antibodi
titer
sarscov
mean
immunofluoresc
test
n
elisa
perform
briefli
serum
ad
well
microtit
plate
coat
mixtur
three
antin
protein
monoclon
antibodi
plate
incub
min
plate
wash
antin
rabbit
antiserum
ad
well
plate
incub
min
well
wash
incub
h
peroxidaseconjug
goat
antirabbit
immunoglobulin
g
igg
plate
wash
tetramethylbenzidin
solut
ad
well
experi
involv
use
serum
sampl
patient
sar
perform
within
safeti
cabinet
biosafeti
level
laboratori
result
serum
specimen
test
n
elisa
shown
figur
n
protein
could
detect
earli
day
day
serum
sampl
posit
n
protein
optic
densiti
od
valu
highli
variabl
one
sampl
anoth
day
sensit
detect
patient
blood
sampl
taken
first
day
patient
sampl
taken
day
onset
symptom
detect
rate
n
protein
decreas
day
onset
symptom
serum
n
protein
never
detect
beyond
day
use
panel
patient
serum
sampl
measur
n
igg
sarscov
nigg
igg
sarscov
igg
serum
sampl
indirect
elisa
progress
increas
day
onward
figur
appear
antibodi
n
protein
detect
rate
decreas
day
onset
symptom
howev
day
day
high
level
n
protein
still
detect
serum
sampl
patient
mean
od
valu
sarscov
nigg
alreadi
increas
level
mean
od
valu
serum
sampl
patient
collect
year
previous
use
neg
control
patient
thought
case
sar
admiss
later
found
uninfect
serolog
test
healthcar
worker
close
contact
sar
patient
test
circul
n
protein
serum
sampl
nonsar
patient
collect
year
previous
n
one
weakli
posit
n
protein
od
test
total
acutephas
serum
sampl
patient
initi
consid
suspect
sar
later
proven
neg
sarscov
serolog
test
convalescentphas
serum
sampl
taken
day
onset
symptom
serum
sampl
healthcar
worker
neg
n
protein
captur
elisa
find
result
test
specif
result
suggest
n
protein
serum
sampl
sar
patient
detect
earli
day
diseas
onset
although
level
circul
n
protein
highli
variabl
one
person
anoth
day
day
develop
sarscov
nigg
appear
affect
n
protein
acut
phase
infect
day
onset
symptom
posit
detect
rate
n
protein
serum
sampl
within
first
day
infect
higher
detect
rtpcr
furthermor
variat
report
sensit
specif
rtpcr
may
relat
lack
standard
assay
specimen
collect
therefor
viral
antigencaptur
elisa
may
greater
sensit
specif
eas
reliabl
inus
perform
nucleic
acid
amplif
assay
compar
studi
nucleic
acid
amplif
test
undertaken
clinic
laboratori
serv
acutecar
hospit
rapid
sar
diagnosi
vital
